Tissue transglutaminase modulates pain but not neuronal survival after nerve injury

Abstract

Aim: Tissue transglutaminase [transglutaminase 2 (TG2)] is implicated in central neuronal apoptosis and is expressed in the peripheral nervous system; however, its role in sensory neuron survival and neuropathic pain after nerve injury remains poorly defined. This study examined whether TG2 knockout (KO) affects dorsal root ganglion (DRG) neuron survival and pain-related behaviors following sciatic nerve injury.

Methods: TG2 KO mice and wild-type (WT) controls underwent complete sciatic nerve transection (axotomy). Pain-related behavior was evaluated using detailed autotomy scoring over 14 days. DRG neuron survival was assessed using unbiased stereological counts.

Results: TG2 KO resulted in a distinct, previously unreported “atypical autotomy” pattern, with lesions localized mainly to the midplantar paw region. In contrast, WT mice exhibited typical autotomy directed primarily at the toes. Despite this clear difference in pain phenotype, stereological analysis revealed that TG2 KO did not alter neuronal counts in intact or axotomized DRGs, with both groups showing comparable, significant neuronal loss after injury.

Conclusions: These findings indicate that TG2 functions as an important modulator of neuropathic pain but is not required for neuronal survival in the adult DRG following nerve injury.

Keywords

abnormal sensation / sensory neurons / tissue TG / self-mutilation

References

[1] Tabolacci C, De Martino A, Mischiati C, Feriotto G, Beninati S. The Role of Tissue Transglutaminase in Cancer Cell Initiation, Survival and Progression. Med Sci (Basel). 2019; 7:19.

[2] Kuo TF, Tatsukawa H, Kojima S. New insights into the functions and localization of nuclear transglutaminase 2. FEBS J. 2011; 278:4756-67.

[3] Bailey CD, Johnson GV. Developmental regulation of tissue transglutaminase in the mouse forebrain. J Neurochem. 2004; 91:1369-79.

[4] Facchiano F, Deloye F, Doussau F, Innamorati G, Ashton AC, Dolly JO, et al.Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function. Amino Acids. 2010; 39:257-69.

[5] Karpuj MV, Becher MW, Steinman L. Evidence for a role for transglutaminase in Huntington’s disease and the potential therapeutic implications. Neurochem Int. 2002; 40:31-6.

[6] Mastroberardino PG, Iannicola C, Nardacci R, Bernassola F, De Laurenzi V, Melino G, et al.‘Tissue’ transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington’s disease. Cell Death Differ. 2002; 9:873-80.

[7] Tetzlaff W, Gilad VH, Leonard C, Bisby MA, Gilad GM. Retrograde changes in transglutaminase activity after peripheral nerve injuries. Brain Res. 1988; 445:142-6.

[8] Gilad GM, Varon LE, Gilad VH. Calcium-dependent transglutaminase of rat sympathetic ganglion in development and after nerve injury. J Neurochem. 1985; 44:1385-90.

[9] Matà S, Renzi D, Pinto F, Calabrò A. Anti-tissue transglutaminase IgA antibodies in peripheral neuropathy and motor neuronopathy. Acta Neurol Scand. 2006; 114:54-8.

[10] Navarro X, Vivó M, Valero-Cabré A. Neural plasticity after peripheral nerve injury and regeneration. Prog Neurobiol. 2007; 82:163-201.

[11] Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999; 194:1-14.

[12] Shi TJ, Tandrup T, Bergman E, Xu ZQ, Ulfhake B, Hökfelt T. Effect of peripheral nerve injury on dorsal root ganglion neurons in the C57 BL/6J mouse: marked changes both in cell numbers and neuropeptide expression. Neuroscience. 2001; 105:249-63.

[13] Decosterd I, Woolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain. 2000; 87:149-58.

[14] Wall PD, Devor M, Inbal R, Scadding JW, Schonfeld D, Seltzer Z, et al.Autotomy following peripheral nerve lesions: experimental anaesthesia dolorosa. Pain. 1979; 7:103-13.

[15] Shi TJ, Liu SX, Hammarberg H, Watanabe M, Xu ZQ, Hökfelt T. Phospholipase Cβ3 in mouse and human dorsal root ganglia and spinal cord is a possible target for treatment of neuropathic pain. Proc Natl Acad Sci U S A. 2008; 105:20004-8.

[16] Wagner FW Jr. The dysvascular foot: a system for diagnosis and treatment. Foot Ankle. 1981; 2:64-122.

[17] American Diabetes Association Professional Practice Committee. 4. Comprehensive Medical Evaluation and Assessment of Comorbidities: Standards of Care in Diabetes—2025. Diabetes Care. 2025; 48:S59-85.

[18] Kotulska K, LePecheur M, Marcol W, Lewin-Kowalik J, Larysz-Brysz M, Paly E, et al.Overexpression of copper/zinc-superoxide dismutase in transgenic mice markedly impairs regeneration and increases development of neuropathic pain after sciatic nerve injury. J Neurosci Res. 2006; 84:1091-7.

[19] Lyu C, Lyu GW, Martinez A, Shi TS. Effect of nerve injury on the number of dorsal root ganglion neurons and autotomy behavior in adult Bax-deficient mice. J Pain Res. 2017; 10:2079-87.

[20] Gundersen HJ, Jensen EB. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987; 147:229-63.

[21] Coderre TJ, Grimes RW, Melzack R. Deafferentation and chronic pain in animals: an evaluation of evidence suggesting autotomy is related to pain. Pain. 1986; 26:61-84.

[22] Blumenkopf B, Lipman JJ. Studies in autotomy: its pathophysiology and usefulness as a model of chronic pain. Pain. 1991; 45:203-9.

[23] Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature’s biological glues. Biochem J. 2002; 368:377-96.

[24] Jones RA, Kotsakis P, Johnson TS, Chau DY, Ali S, Melino G, et al.Matrix changes induced by transglutaminase 2 lead to inhibition of angiogenesis and tumor growth. Cell Death Differ. 2006; 13:1442-53.

[25] Barros CS, Franco SJ, Müller U. Extracellular matrix: functions in the nervous system. Cold Spring Harb Perspect Biol. 2011; 3:a005108.

[26] Metafune M, Muratori L, Fregnan F, Ronchi G, Raimondo S. The extracellular matrix in peripheral nerve repair and regeneration: a narrative review of its role and therapeutic potential. Front Neuroanat. 2025; 19:1628081.

[27] Mai L, Zhu X, Huang F, He H, Fan W. p38 mitogen-activated protein kinase and pain. Life Sci. 2020; 256:117885.

[28] Ji RR, Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE. 2004; 2004:re14.